Results 211 to 220 of about 2,787,448 (332)

Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease

open access: yesAmerican Journal of Hematology, Volume 100, Issue 5, Page 785-796, May 2025.
ABSTRACT Pyruvate kinase (PK) is a key enzyme involved in the final step of glycolysis, essential to produce adenosine triphosphate (ATP). Relatively decreased red blood cell (RBC) PK activity (reflected by a lower PK/hexokinase [HK] ratio) and PK thermostability (PK activity after exposure to heat) were recently identified as pathophysiological ...
M. J. M. Traets   +17 more
wiley   +1 more source

Outpatient Consultation in Allergy/Immunology [PDF]

open access: bronze, 2008
Jörg Dietrich   +2 more
openalex   +1 more source

Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo‐Lymphoid Morphology Mimicking Lymphoid Malignancy

open access: yes
American Journal of Hematology, EarlyView.
Romain Ravel‐Chapuis   +7 more
wiley   +1 more source

Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria

open access: yesAmerican Journal of Hematology, Volume 100, Issue 5, Page 830-839, May 2025.
ABSTRACT Transplant‐associated thrombotic microangiopathy (TA‐TMA) is an endothelial dysfunction syndrome observed after allogeneic hematopoietic cell transplant (alloHCT). Our aim was to externally validate the impact of high‐risk features on the clinical outcomes of adult patients meeting the updated TA‐TMA harmonizing criteria. Between 2005 and 2022,
Aldo A. Acosta‐Medina   +19 more
wiley   +1 more source

TP53 ‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

open access: yesAmerican Journal of Hematology, Volume 100, Issue S4, Page 88-115, June 2025.
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53 mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah   +2 more
wiley   +1 more source

Clinical competencies in allergy and immunology: Results of a graduate survey

open access: bronze, 2002
James T. Li   +3 more
openalex   +1 more source

Testing of IgG and IgG4 to foods is not recommended / Position of the German Society of Allergy and Clinical Immunology (DGAKI) a , the Physician's Society of German Allergists (ÄDA) and the Society of Pediatric Allergy and Environmental Medicine (GPA), the Austrian Society of Allergy and Immunology (ÖGAI) and the Swiss Society of Allergy and Immunology (SGAI) after Adoption of the Task Force Report b of the European Academy of Allergy and Clinical Immunology (EAACI) [PDF]

open access: green, 2010
Jörg Kleine‐Tebbe   +19 more
openalex   +1 more source

Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future

open access: yesAmerican Journal of Hematology, Volume 100, Issue S4, Page 5-15, June 2025.
ABSTRACT With the recent publication of new classification systems of hematopoietic neoplasms, understanding how recognition of disease entities has occurred over time and the subsequent development of formal disease classifications is of importance. This review focuses on the early recognition of myeloid disorders, especially chronic myeloid disorders,
Daniel A. Arber, Attilio Orazi
wiley   +1 more source

Distribution of primary immunodeficiency diseases diagnosed in pediatric allergy and immunology clinic

open access: bronze, 2002
Arnaldo Carlos Porto Neto   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy